EICHOR
● Active Not Recruiting
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Condition: Fistulizing Crohns Disease · Perianal Crohns Disease · Sponsor: Janssen-Cilag Ltd.
About this study
The purpose of this study to evaluate the clinical efficacy of guselkumab in fistulizing, perianal Crohn's disease and to assess the overall safety of guselkumab.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (154)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Yale University | New Haven, Connecticut, United States | — |
| University of Miami | Miami, Florida, United States | — |
| Gastroenterology Group Of Naples | Naples, Florida, United States | — |
| AdventHealth Medical Group Blood & Marrow Transplant at Orlando | Orlando, Florida, United States | — |
| Kansas University Medical Center | Kansas City, Kansas, United States | — |
| University of Kentucky Chandler Medical Center | Lexington, Kentucky, United States | — |
| University of Louisville | Louisville, Kentucky, United States | — |
| Washington University School Of Medicine | St Louis, Missouri, United States | — |
| Mount Sinai School of Medicine | New York, New York, United States | — |
| Digestive Disease Specialists Inc | Oklahoma City, Oklahoma, United States | — |
| Gastro One | Germantown, Tennessee, United States | — |
+ 142 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.